Larisa H. Cavallari
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
2017/02/15 by JA Johnson, KE Caudle, L Gong +23 · 29 citations
Pharmacology, Toxicology and Pharmaceutics · Medicine · #Pharmacogenetics and Drug Metabolism #Hormonal Regulation and Hypertension #Inflammatory mediators and NSAID effects
- The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems
2017/01/16 by JA Luzum, Jasmine A. Luzum, R E Pakyz +39 · 26 citations
Pharmacology, Toxicology and Pharmaceutics · Economics, Econometrics and Finance · Medicine · #Pharmacogenetics and Drug Metabolism #Health Systems, Economic Evaluations, Quality of Life #Pharmaceutical studies and practices
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
2021/01/02 by Kristine R. Crews, Andrew A. Monte, Rachel Huddart +18 · 3 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Diet and metabolism studies #Pharmaceutical studies and practices #Pharmacogenetics and Drug Metabolism
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing
2020/08/08 by John J. Lima, Cameron D. Thomas, Julia Barbarino +19 · 26 citations
Medicine · #Gastroesophageal reflux and treatments #Helicobacter pylori-related gastroenterology studies #Potassium and Related Disorders
- Pharmacogenetics and Cardiovascular Disease—Implications for Personalized Medicine
2013/07/01 by Julie A. Johnson, Larisa H. Cavallari · 26 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Antiplatelet Therapy and Cardiovascular Diseases #Pharmacogenetics and Drug Metabolism #Hormonal Regulation and Hypertension